Form 4: Arteris CFO Nicholas Hawkins Executes Pre-Planned Stock Sales Totaling 11,276 Shares
Insider Transaction Report
Arteris, Inc.'s VP and Chief Financial Officer, Nicholas B. Hawkins, sold a total of 11,276 shares of common stock in two transactions in late June and early July 2025, pursuant to a pre-arranged 10b5-1 trading plan.
Summary
- Nicholas B. Hawkins, VP and Chief Financial Officer of Arteris, Inc. (AIP), reported two sales of common stock.
- On June 27, 2025, Hawkins sold 5,638 shares of Common Stock at a price of $10.00 per share.
- Following the June 27, 2025 transaction, Hawkins beneficially owned 145,023 shares of Common Stock.
- On July 1, 2025, Hawkins sold an additional 5,638 shares of Common Stock at a weighted average sale price of $9.0806 per share.
- The shares sold on July 1, 2025, were transacted in multiple sales at prices ranging from $8.72 to $9.37.
- After both reported transactions, Hawkins' beneficial ownership of Common Stock stands at 139,385 shares.
- Both transactions were executed under a Rule 10b5-1 trading plan, which was adopted by Mr. Hawkins on May 20, 2024.
Sentiment
Score: 5
Explanation: The sentiment is neutral. While it's an insider sale, it was conducted under a pre-arranged 10b5-1 plan, which is a common and transparent practice for executives to manage their equity holdings for personal financial planning.
Positives
- The stock sales were conducted under a Rule 10b5-1 trading plan, indicating they were pre-scheduled and not based on immediate, non-public information, which enhances transparency and reduces concerns about opportunistic insider selling.
Negatives
- The transactions represent a reduction in the direct beneficial ownership of Arteris, Inc. common stock by a key executive, decreasing his holdings from 145,023 shares to 139,385 shares after the reported sales.
Future Outlook
The document does not provide any forward-looking statements or guidance regarding the company's future performance or strategic direction.
Management Comments
- The transactions were made pursuant to a 10b5-1 trading plan that was adopted by the Reporting Person on May 20, 2024.
Industry Context
This Form 4 filing is a routine disclosure of an insider stock transaction and does not provide broader industry context or trends.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Policy Implementation | The use of a Rule 10b5-1 trading plan by the VP and CFO demonstrates adherence to corporate governance best practices for orderly insider stock transactions, reducing the risk of perceived opportunistic trading. | 05/20/2024 | Enhances transparency and mitigates potential concerns related to insider trading by pre-scheduling sales. |
Related Party Transactions
- The reported transactions involve the sale of company stock by a key executive (Nicholas B. Hawkins, VP and CFO), which is a direct related-party transaction.
Stakeholder Impact
- Shareholders: The sale reduces the direct ownership stake of a key executive, which some investors might monitor as an indicator of management's confidence, though the 10b5-1 plan mitigates this concern.
Key Dates
| Date | Description |
|---|---|
| 05/20/2024 | Date the 10b5-1 trading plan was adopted by Nicholas B. Hawkins. |
| 06/27/2025 | Date of the first reported sale of 5,638 shares of Common Stock at $10.00 per share. |
| 07/01/2025 | Date of the second reported sale of 5,638 shares of Common Stock at a weighted average price of $9.0806 per share. |
Keywords
Arteris Inc., AIP, Nicholas B. Hawkins, Insider Trading, Stock Sale, Form 4, Beneficial Ownership, 10b5-1 Plan, Chief Financial Officer
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.